©The Author(s) 2026.
World J Clin Oncol. Jan 24, 2026; 17(1): 112801
Published online Jan 24, 2026. doi: 10.5306/wjco.v17.i1.112801
Published online Jan 24, 2026. doi: 10.5306/wjco.v17.i1.112801
Figure 7 Forest plot of odds ratios with 95% confidence intervals from multivariate logistic regression for stage IV lymphoma in patients with lymphoproliferative neoplasms (n = 90).
Parameters include the systemic immune-inflammation index, systemic inflammation response index, programmed death-ligand 1/C-X-C motif chemokine receptor 3 (CXCR3), and programmed cell death protein 1/CXCR3. Dark blue indicates a non-significant association (P ≥ 0.05) for the systemic immune-inflammation index, and dark red indicates significant associations (P < 0.05) for systemic inflammation response index, programmed cell death protein 1/CXCR3, and programmed cell death protein 1/CXCR3, adjusted for age, sex, and subtype. SII: Systemic immune-inflammation index; SIRI: Systemic inflammation response index; PD-L1: Programmed death-ligand 1; CXCR3: C-X-C motif chemokine receptor 3; PD-1: Programmed cell death protein 1; OR: Odds ratio; CI: Confidence interval.
- Citation: Sherief DE, Nosair N, Abdelhameed AM, Sadaka E, Othman AAA, Elgamal R. Prognostic significance of PD-L1/PD-1 co-expression and CXCR3-driven inflammatory signatures in Egyptian patients with lymphoproliferative neoplasms. World J Clin Oncol 2026; 17(1): 112801
- URL: https://www.wjgnet.com/2218-4333/full/v17/i1/112801.htm
- DOI: https://dx.doi.org/10.5306/wjco.v17.i1.112801